傷跡治療市場- 世界の産業規模、シェア、動向、機会、予測、製品別、傷跡製品別、エンドユーザー別、地域別、市場競合、2020-2030年

傷跡治療の世界市場は、2024年に28億7,000万米ドルと評価され、予測期間中のCAGRは11.38％を記録し、2030年には54億8,000万米ドルに達すると予測されています。

市場成長の主な原動力は、美的外観に対する意識の高まり、交通事故や火傷によるケースの増加、高度な治療装置を導入する技術革新です。COVID-19の大流行は、初診や経過観察のための遠隔医療の利用を加速させ、頻繁に病院を訪れる必要なく傷跡治療をより利用しやすくすることで、市場にさらなる影響を与えました。米国形成外科学会（American Society of Plastic Surgeons）によると、2022年には米国で約5万930件の瘢痕修正手術が行われ、美容整形手術の増加傾向が浮き彫りになりました。審美的な改善を追求することで、外科的および非外科的な傷跡治療ソリューションの採用が増加しています。

市場促進要因

交通事故と火傷の発生率の上昇

主な市場課題

高度な傷跡治療処置の高コスト

主要市場動向

傷跡治療モダリティの技術的進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の傷跡治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（外用剤、レーザー製品、注射剤、その他）
  • 瘢痕製品別（萎縮性瘢痕、肥厚性瘢痕およびケロイド瘢痕、拘縮瘢痕、ストレッチマーク）
  • エンドユーザー別（病院・診療所、外来診療センター、その他）
  • 地域別
  • 企業別（2024）
• 製品マップ
  • 製品別
  • 傷跡の種類別
  • エンドユーザー別
  • 地域別

第6章 北米の傷跡治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の傷跡治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の傷跡治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の傷跡治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの傷跡治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の傷跡治療市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Smith & Nephew PLC
• Lumenis Ltd.
• Merz Pharmaceuticals, LLC
• Sonoma Pharmaceuticals, Inc.
• Cynosure, LLC
• CCA Industries, Inc.
• Newmedical Technology Inc.
• Molnlycke Health Care AB
• Perrigo Company plc
• Enaltus LLC

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Scar Treatment Market was valued at USD 2.87 billion in 2024 and is projected to reach USD 5.48 billion by 2030, registering a CAGR of 11.38% during the forecast period. Market growth is primarily driven by increasing awareness around aesthetic appearance, rising cases of road and burn injuries, and technological innovations introducing advanced treatment devices. The COVID-19 pandemic further influenced the market by accelerating the use of telemedicine for initial consultations and follow-up care, making scar treatment more accessible without the need for frequent hospital visits. According to the American Society of Plastic Surgeons, approximately 50,930 scar revision surgeries were conducted in the U.S. in 2022, highlighting a rising trend in cosmetic procedures. The pursuit of aesthetic improvement is leading to increased adoption of both surgical and non-surgical scar treatment solutions.

Key Market Drivers

Rising Incidence of Road Accidents and Burn Injuries

The global scar treatment market is being largely influenced by the surge in road accidents and burn injuries. Data from the Population Reference Bureau indicates that about 50 million individuals suffer road accident injuries annually, many of whom require scar treatment. In the U.S., the CDC notes around 1.1 million burn injuries each year that require medical care, with roughly 50,000 cases necessitating hospitalization. These conditions frequently result in hypertrophic and keloid scars, causing both physical and emotional distress. This drives up demand for treatment options such as laser therapies, topical products, and surgeries. Additionally, government-backed reimbursement policies in countries like the U.S. further support access to these treatments, encouraging advancements and investment in the scar treatment industry.

Key Market Challenges

High Cost of Advanced Scar Treatment Procedures

A key obstacle in the scar treatment market is the considerable cost of advanced therapies, including laser treatments and surgical options. These high expenses can be prohibitive, especially in developing nations, where access to such services is limited. The situation is worsened by the general lack of insurance coverage for aesthetic treatments, forcing patients to pay out-of-pocket. This economic constraint limits market expansion and highlights the need for cost-effective treatment alternatives. Addressing this issue calls for coordinated action among stakeholders to explore affordable innovations and insurance solutions that make scar treatment more accessible.

Key Market Trends

Technological Advancements in Scar Treatment Modalities

Technological innovation is significantly enhancing scar treatment outcomes, improving both effectiveness and patient safety. Cutting-edge laser technologies such as Q-switched and fractional CO2 lasers are transforming the treatment of various scars. A notable advancement includes Cynosure's PicoSure Pro Device, launched in June 2022, aimed at treating acne scars, wrinkles, and pores. Simultaneously, the integration of telemedicine is reshaping how care is delivered. The rise of remote consultations and follow-ups-accelerated by the COVID-19 pandemic-has made scar treatment more convenient and accessible, especially for individuals in underserved or remote locations.

Key Market Players

• Smith & Nephew PLC
• Lumenis Ltd.
• Merz Pharmaceuticals, LLC
• Sonoma Pharmaceuticals, Inc.
• Cynosure, LLC
• CCA Industries, Inc.
• Newmedical Technology Inc.
• Molnlycke Health Care AB
• Perrigo Company plc
• Enaltus LLC

Report Scope:

In this report, the global scar treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Scar Treatment Market, By Product:

• Topical Products
• Laser Products
• Injectables
• Others

Scar Treatment Market, By Scar Product:

• Atrophic Scars
• Hypertrophic & Keloid Scars
• Contracture Scars
• Stretch Marks

Scar Treatment Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Scar Treatment Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Scar Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Scar Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Topical Products, Laser Products, Injectables, Others)
  • 5.2.2. By Scar Product (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, Stretch Marks)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Map
  • 5.3.1. By Product
  • 5.3.2. By Scar Type
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Scar Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Scar Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Scar Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Scar Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Scar Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Scar Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Scar Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Scar Type
      • 6.3.3.2.3. By End User

7. Europe Scar Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Scar Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Scar Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Scar Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Scar Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Scar Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Scar Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Scar Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Scar Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Scar Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Scar Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Scar Type
      • 7.3.5.2.3. By End User

8. Asia-Pacific Scar Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Scar Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Scar Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Scar Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Scar Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Scar Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Scar Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Scar Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Scar Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Scar Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Scar Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Scar Type
      • 8.3.5.2.3. By End User

9. South America Scar Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Scar Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Scar Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Scar Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Scar Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Scar Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Scar Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Scar Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Scar Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Scar Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Scar Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Scar Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Scar Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Scar Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Scar Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Scar Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Scar Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Smith & Nephew PLC
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Lumenis Ltd.
• 15.3. Merz Pharmaceuticals, LLC
• 15.4. Sonoma Pharmaceuticals, Inc.
• 15.5. Cynosure, LLC
• 15.6. CCA Industries, Inc.
• 15.7. Newmedical Technology Inc.
• 15.8. Molnlycke Health Care AB
• 15.9. Perrigo Company plc
• 15.10. Enaltus LLC

16. Strategic Recommendations

17. About Us & Disclaimer